in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
DSM Net Income Rises 24%
11:14 AM MDT | November 3, 2011 | Alex Scott
DSM reported net income for the for the third quarter excluding one-time items up 24%, to €159 million ($217 million), compared with the year-ago period on corresponding sales up 14% to €2.3 billion. The company saw growth across all businesses, despite a strong Swiss franc and a weak U.S. dollar, says DSM CEO Feike Sijbesma. The company saw growth across all of its businesses, despite a strong Swiss franc and a weak U.S. dollar, says Feike Sijbesma, CEO of the company. Although the company has been experiencing weakening demand for its...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee